APA (7th ed.) Citation

M, Z., M, S., M, T., N, E., & F, G. (2026). Rethinking MS Therapeutics: From Disease Pathogenesis Mechanisms to AI-Driven Drug Discovery. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 21(1), . https://doi.org/10.1007/s11481-026-10286-x

Chicago Style (17th ed.) Citation

M, Ziaei, Sehhati M, Torabi M, Esmaeil N, and Ghasemi F. "Rethinking MS Therapeutics: From Disease Pathogenesis Mechanisms to AI-Driven Drug Discovery." Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology 21, no. 1 (2026). https://doi.org/10.1007/s11481-026-10286-x.

MLA (9th ed.) Citation

M, Ziaei, et al. "Rethinking MS Therapeutics: From Disease Pathogenesis Mechanisms to AI-Driven Drug Discovery." Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology, vol. 21, no. 1, 2026, https://doi.org/10.1007/s11481-026-10286-x.